Dev Labtech Venture Ltd (543848)
சுருக்கம்
நிகழ்வுகள்
- சமீபத்திய முடிவுகள்
- H1 FY27, filed 6 Nov 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 3 அக். 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
H1 FY27 முடிவுகள்
Dev Labtech Venture Ltd reported H1 FY27 results on 6 Nov 2026: revenue ₹155 Cr (+216.7% year on year, +31.5% on the previous half-year), and net profit ₹9.0 Cr; the operating margin was 6.3%.
| H1 FY27 (₹ கோடி) | மதிப்பு | YoY H1 FY26-உடன் | முந்தைய அரையாண்டுடன் ஒப்பீடு |
|---|---|---|---|
| வருவாய் | ₹155 | +216.7% | +31.5% |
| செயல்பாட்டு லாபம் | ₹9.8 | +882.1% | -1.8% |
| நிகர லாபம் | ₹9.0 | — | +0.5% |
| EPS (₹) | 1.91 | — | -2.1% |
| செயல்பாட்டு லாப வரம்பு | 6.3% | — | — |
No EPS growth against H1 FY26: ₹10 to ₹5 split in May 2026 and 1:1 bonus in May 2026.
- செயல்பாட்டு லாப வரம்பு 429 bps YoY அதிகரித்தது
லாபத்தின் தரம்: வரிக்கு முந்தைய ₹9.0 கோடி லாபத்தில், ₹8.9 கோடி (99%) முக்கிய வணிகத்திலிருந்து வந்தது; மீதம் பிற வருமானம் மற்றும் ஒருமுறை வரவுகளிலிருந்து வந்தது.
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Dev Labtech Venture reported standalone revenue from operations of ₹34.33 crore for the half-year ended September 30, 2026, down 30.3% YoY from ₹49.24 crore. Net profit for the half-year dropped 63.4% YoY to ₹12.31 lakh compared to ₹33.67 lakh in H1 FY26. Subsequent to the half-year, shareholders approved an issuance of up to 1.37 crore convertible warrants at ₹13 per warrant, raising ₹17.81 crore (~22% of current market cap) on a preferential basis to promoters and non-promoters.
- H1 FY27 standalone revenue fell 30.3% YoY to ₹34.33 crore vs ₹49.24 crore in H1 FY26
- Standalone net profit declined 63.4% YoY to ₹12.31 lakh vs ₹33.67 lakh in H1 FY26
- Basic EPS for H1 FY27 declined to ₹0.03 from ₹0.29 in H1 FY26
- Operating cash flow stood at ₹4.65 crore for H1 FY27
- Approved preferential issue of up to 1.37 crore convertible warrants at ₹13 each, aggregating ₹17.81 crore
Dev Labtech Venture Limited's shareholders have approved the issuance of up to 1,37,00,000 convertible warrants at a price of ₹13 per warrant, raising up to ₹17.81 crore. The fundraise represents approximately 22% of the company's current market capitalization of ₹81 crore. Warrants will be allotted across 7 investors, with the promoter group receiving 1.0792 crore warrants and non-promoters receiving 29.08 lakh warrants. Following full conversion within the 18-month tenure, promoter holding will rise from 56.7% to 61.64%.
- Shareholders approved issue of up to 1,37,00,000 convertible warrants at ₹13 each, aggregating ₹17.81 crore
- Fundraise equals ~22% of the company's market cap of ₹81 crore and ~40% of net worth (₹44 crore)
- Issue price of ₹13 includes face value of ₹5 and a premium of ₹8 per share
- Post conversion, promoter and promoter group shareholding increases from 56.69% to 61.64%
- Warrants have a conversion tenure of 18 months from the date of allotment
Dev Labtech Venture Limited has issued an EGM notice for November 5, 2026, to approve a preferential issue of up to 1.37 crore convertible warrants at ₹13 each, aggregating to ₹17.81 crore. The warrants will be allotted to promoter and non-promoter entities, with promoters receiving 1.08 crore warrants. The fundraise represents approximately 22% of the company's current market cap of ₹81 crore and 40.5% of its net worth (₹44 crore). Additionally, the company seeks shareholder approval to increase its authorized share capital from ₹25 crore to ₹31 crore.
- Proposed preferential issue of 1,37,00,000 convertible warrants at ₹13 per warrant aggregating to ₹17.81 crore
- Issue price of ₹13 represents a discount to the current market price of ₹18.7
- Promoters/Promoter Group to be allocated 1,07,92,000 warrants (78.8% of the issue)
- Authorized share capital proposed to increase from ₹25.00 crore to ₹31.00 crore
- EGM scheduled for Thursday, November 5, 2026 at 1:00 PM via VC/OAVM
Dev Labtech Venture Ltd's board approved the preferential issuance of up to 1.37 crore convertible warrants at ₹13 per warrant, aggregating to ₹17.81 crore. The warrants are being issued to promoters and non-promoter investors, with promoter holding slated to rise to 61.64% from 56.69% post-conversion. The warrant price of ₹13 represents a discount to the current market price of ₹18.7. To facilitate this, the board also approved increasing the authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at an EGM on November 5, 2026.
- Issuance of up to 1,37,00,000 convertible warrants at ₹13 each (aggregating ₹17,81,00,000)
- Post-conversion promoter shareholding will increase to 61.64% (from 56.69%), while non-promoters will hold 38.36%
- Authorized share capital increased from ₹25,00,00,000 (5 crore shares) to ₹31,00,00,000 (6.2 crore shares)
- Warrant tenor is 18 months, exercisable into equity shares of face value ₹5 at a ₹8 premium
- EGM scheduled for November 5, 2026 with a voting cut-off date of October 29, 2026
Dev Labtech Venture Ltd has scheduled a Board of Directors meeting on October 7, 2026, to evaluate proposals for raising funds via preferential allotment of equity shares or convertible securities. The board will also consider an increase in the company's authorized share capital. With a current market capitalization of ₹81 Cr, any significant preferential issue could lead to meaningful equity dilution. Trading window for insiders has been closed effective October 2, 2026.
- Board meeting scheduled for October 7, 2026, at 3:00 PM
- Proposal to increase authorized share capital under consideration
- Evaluation of fundraise via preferential issue of equity shares or convertible securities
- Insider trading window closed from October 2, 2026 until 48 hours post announcement
Dev Labtech Venture Limited has announced the outcome of its Board Meeting held on August 27, 2026. The Board approved the Directors' Report for the financial year ended March 31, 2026. Additionally, the 33rd Annual General Meeting (AGM) has been scheduled for September 26, 2026, via Video Conferencing. The cut-off date to determine eligibility for e-voting has been fixed as September 19, 2026.
- 33rd Annual General Meeting (AGM) scheduled for September 26, 2026, at 01:00 p.m. via VC/OAVM.
- Cut-off date for e-voting eligibility fixed as Saturday, September 19, 2026.
- Appointed NSDL to provide the e-voting platform.
- Appointed Mr. Ricky Kapadia (RPK & Associates) as the scrutinizer for voting processes.
Dev Labtech Venture Ltd has approved availing a ₹2.10 crore credit facility from HDFC Bank to support its operations. This facility is relatively small, representing approximately 1.9% of its TTM revenue of ₹112 crore. Additionally, the board has reversed its January 2026 decision to strike off its US-based wholly-owned subsidiary, Dev Labtech Venture Inc., citing new strategic expansion plans. This pivot suggests a renewed focus on international markets despite the company's thin TTM PAT of ₹1 crore.
- Approved a new credit facility of ₹2.10 crore from HDFC Bank.
- Withdrew the voluntary strike-off proposal for US subsidiary Dev Labtech Venture Inc. originally dated January 22, 2026.
- The credit facility represents ~4.8% of the company's current net worth of ₹44 crore.
- The company reported a significant revenue drop in Mar 2026 (₹10.05 cr) compared to Sep 2025 (₹49.24 cr).
- Management states the retention of the US arm will not have a material adverse impact on financials.
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
